Evidence map›Paper›PMID 35012349›Full record

ArticlemBio2022

The Role of Fatty Acid Metabolism in Drug Tolerance of Mycobacterium tuberculosis.

Camila G Quinonez, Jae Jin Lee, Juhyeon Lim, Mark Odell, Christopher P Lawson, Amararachukwu Anyogu, Saki Raheem, Hyungjin Eoh

Open access · goldAbstract read
In one paragraph

Article in mBio, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 1 pooled it
5.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Meta-analysis reveals a core iron-responsive gene signature in Mycobacterium tuberculosis linking siderophore biosynthesis, virulence, and metabolic adaptation.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Pooled it
  2. Biofilm Associated Persistence and Drug Tolerance in Mycobacteria Within Host Microenvironments.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026
    Review
  3. Article
  4. Heteroresistance inFrontiers in cellular and infection microbiology · 2026
    Review
  5. Article
  6. Variability in intrinsic drug tolerance inAntimicrobial agents and chemotherapy · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Enhancement of mycobacterial pathogenesis by host interferon-γ.Cellular and molecular life sciences : CMLS · 2024
    Article
  15. Review
  16. Review
  17. Article
  18. mBio · 2024
    Article
  19. Metabolic Rewiring ofMetabolites · 2024
    Review
  20. The PDIM paradox ofbioRxiv : the preprint server for biology · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Camila G Quinonez *Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.ORCID 0000-0002-1316-2290
Jae Jin Lee *Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Juhyeon LimDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
Mark OdellDepartment of Life Sciences, Faculty of Science and Technology, University of Westminstergrid.12896.34, London, United Kingdom.
Christopher P LawsonStrathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclydegrid.11984.35, Glasgow, United Kingdom.
Amararachukwu AnyoguDepartment of Life Sciences, Faculty of Science and Technology, University of Westminstergrid.12896.34, London, United Kingdom.
Saki RaheemDepartment of Life Sciences, Faculty of Science and Technology, University of Westminstergrid.12896.34, London, United Kingdom.ORCID 0000-0003-1691-4483
Hyungjin EohDepartment of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.ORCID 0000-0001-8774-6400
University of Southern California · USUniversity of Lincoln · GBUniversity of Strathclyde · GBUniversity of West London · GBUniversity of Westminster · GB

Funding

Metabolic compensation in Mycobacterium tuberculosis for the formation of persistersR21AI139386 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EOH, HYUNGJIN · 2019 to 2020
$454k
PknG mediated tailoring Mycobacterium tuberculosis adaptive metabolism is required for the persister formationR56AI143870 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EOH, HYUNGJIN · 2019 to 2019
$413k
NIAID NIH HHS R21 AI139386NIAID NIH HHS R56 AI143870
6 · The paper itself

Abstract

Mycobacterium tuberculosis can cocatabolize a range of carbon sources. Fatty acids are among the carbons available inside the host's macrophages. Here, we investigated the metabolic changes of the fatty acid-induced dormancy-like state of

Indexed as

Mycobacterium tuberculosisTuberculosisAcetatesCarbonFatty AcidsGlycerolHumansTricarboxylic AcidsAcetatesCarbonFatty AcidsGlycerolTricarboxylic Acidsacetatedrug tolerancefatty acidsmetabolomicsmethylcitrate cycletuberculosis

Identifiers

PMID35012349
PMCPMC8749430
OpenAlexW4206348133

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.